CEUR workshop proceedings最新文献

Objectives: To compare the representation of medicinal products in RxNorm and SNOMED CT and assess the consequences on interoperability.

Methods: To compare the two models, we manually establish equivalences between the types and definitional features of medicinal products entities in RxNorm and SNOMED CT. We highlight their similarities and differences.

Results: Both models share major definitional features including ingredient (or substance), strength and dose form. SNOMED CT is more rigorous and better aligned with international standards. In contrast, RxNorm contains implicit knowledge, simplifications and ambiguities, but its model is simpler.

Conclusions: Since their models are largely compatible, medicinal products from RxNorm and SNOMED CT are expected to be interoperable. However, specific aspects of the alignment between the two models require particular attention.

The emergence of deep learning networks raises a need for explainable AI so that users and domain experts can be confident applying them to high-risk decisions. In this paper, we leverage data from the latent space induced by deep learning models to learn stereotypical representations or "prototypes" during training to elucidate the algorithmic decision-making process. We study how leveraging prototypes effect classification decisions of two dimensional time-series data in a few different settings: (1) electrocardiogram (ECG) waveforms to detect clinical bradycardia, a slowing of heart rate, in preterm infants, (2) respiration waveforms to detect apnea of prematurity, and (3) audio waveforms to classify spoken digits. We improve upon existing models by optimizing for increased prototype diversity and robustness, visualize how these prototypes in the latent space are used by the model to distinguish classes, and show that prototypes are capable of learning features on two dimensional time-series data to produce explainable insights during classification tasks. We show that the prototypes are capable of learning real-world features - bradycardia in ECG, apnea in respiration, and articulation in speech - as well as features within sub-classes. Our novel work leverages learned prototypical framework on two dimensional time-series data to produce explainable insights during classification tasks.

Objectives: To present the new SNOMED CT international medicinal product model.

Methods: We present the main elements of the model, with focus on types of entities and their interrelations, definitional attributes for clinical drugs, and categories of groupers.

Results: We present the status of implementation as of July 2018 and illustrate differences between the original and new models through an example.

Conclusions: Benefits of the new medicinal product model include comprehensive representation of clinical drugs, logical definitions with necessary and sufficient conditions for all medicinal product entities, better high-level organization through distinct categories of groupers, and compliance with international standards.

Our current health applications do not adequately take into account contextual and personalized knowledge about patients. In order to design "Personalized Coach for Healthcare" applications to manage chronic diseases, there is a need to create a Personalized Healthcare Knowledge Graph (PHKG) that takes into consideration a patient's health condition (personalized knowledge) and enriches that with contextualized knowledge from environmental sensors and Web of Data (e.g., symptoms and treatments for diseases). To develop PHKG, aggregating knowledge from various heterogeneous sources such as the Internet of Things (IoT) devices, clinical notes, and Electronic Medical Records (EMRs) is necessary. In this paper, we explain the challenges of collecting, managing, analyzing, and integrating patients' health data from various sources in order to synthesize and deduce meaningful information embodying the vision of the Data, Information, Knowledge, and Wisdom (DIKW) pyramid. Furthermore, we sketch a solution that combines: 1) IoT data analytics, and 2) explicit knowledge and illustrate it using three chronic disease use cases - asthma, obesity, and Parkinson's.

The Cancer Imaging Archive (TCIA) hosts over 11 million de-identified medical images related to cancer for research reuse. These are organized around DICOM-format radiological collections that are grouped by disease type, modality, or research focus. Many collections also include diverse non-image datasets in a variety of formats without a common approach to representing the entities that the data are about. This paper describes work to make these diverse non-image data more accessible and usable by transforming them into integrated semantic representations using Open Biomedical Ontologies, highlights obstacles encountered in the data, and presents detailed representations data found in select collections.

Accurately determining pain levels in children is difficult, even for trained professionals and parents. Facial activity provides sensitive and specific information about pain, and computer vision algorithms have been developed to automatically detect Facial Action Units (AUs) defined by the Facial Action Coding System (FACS). Our prior work utilized information from computer vision, i.e., automatically detected facial AUs, to develop classifiers to distinguish between pain and no-pain conditions. However, application of pain/no-pain classifiers based on automated AU codings across different environmental domains results in diminished performance. In contrast, classifiers based on manually coded AUs demonstrate reduced environmentally-based variability in performance. In this paper, we train a machine learning model to recognize pain using AUs coded by a computer vision system embedded in a software package called iMotions. We also study the relationship between iMotions (automatically) and human (manually) coded AUs. We find that AUs coded automatically are different from those coded by a human trained in the FACS system, and that the human coder is less sensitive to environmental changes. To improve classification performance in the current work, we applied transfer learning by training another machine learning model to map automated AU codings to a subspace of manual AU codings to enable more robust pain recognition performance when only automatically coded AUs are available for the test data. With this transfer learning method, we improved the Area Under the ROC Curve (AUC) on independent data from new participants in our target domain from 0.67 to 0.72.

Accurately determining pain levels in children is difficult, even for trained professionals and parents. Facial activity and electro- dermal activity (EDA) provide rich information about pain, and both have been used in automated pain detection. In this paper, we discuss preliminary steps towards fusing models trained on video and EDA features respectively. We compare fusion models using original video features and those using transferred video features which are less sensitive to environmental changes. We demonstrate the benefit of the fusion and the transferred video features with a special test case involving domain adaptation and improved performance relative to using EDA and video features alone.

Despite the vast number of mobile fitness applications (apps) and their potential advantages in promoting physical activity, many existing apps lack behavior-change features and are not able to maintain behavior change motivation. This paper describes a novel fitness app called CalFit, which implements important behavior-change features like dynamic goal setting and self-monitoring. CalFit uses a reinforcement learning algorithm to generate personalized daily step goals that are challenging but attainable. We conducted the Mobile Student Activity Reinforcement (mSTAR) study with 13 college students to evaluate the efficacy of the CalFit app. The control group (receiving goals of 10,000 steps/day) had a decrease in daily step count of 1,520 (SD ± 740) between baseline and 10-weeks, compared to an increase of 700 (SD ± 830) in the intervention group (receiving personalized step goals). The difference in daily steps between the two groups was 2,220, with a statistically significant p = 0.039.